title: Phase II study of oral miltefosine in patients with squamous cell head and neck cancer.
authors: J
authors: J
authors: Verweij
authors: D
authors: D
authors: Gandia
authors: A S
authors: AS
authors: Planting
authors: G
authors: G
authors: Stoter
authors: J P
authors: JP
authors: Armand
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D005260:Female; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010767:Phosphorylcholine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D010767:Phosphorylcholine; C039128:miltefosine